AB
Last reporting period 30 Jun, 2024
Updated 18 Sep, 2024
Last price
—
Market cap $B
341.7
Exchange
XNYS - New York Stock Exchange, Inc
14.5 B
Last period Revenue ,USD
75%
Revenue has increased in 5 years
What is Revenue ?
Revenue is the total amount of money received by the company from the sale of its goods and services. The presence of revenue is a necessary condition for evaluating a company by Eyestock Rating.
See also Abbvie
Company Analysis
ABBV valuation, rating, competitors, insights and company profile
Eyestock Rating
ABBV financial analysis by Eyestock methodology
Valuation
ABBV valuation using historical relative method
Statements
ABBV Income Statements, Balance Sheet and Cash Flow Statements
Dividends
ABBV dividend yield and annual dividend
Revenue is the total amount of money received by the company from the sale of its goods and services. The presence of revenue is a necessary condition for evaluating a company by Eyestock Rating.
Abbvie`s Revenue for the period ended 2024-06-30 is 14.5 B USD
